The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer A Prospective Trial

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01311037

Enrollment

Registered

2011-03-09

Start date

2009-01-31

Completion date

Unknown

Last updated

2011-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Breast Cancer

Keywords

Premenopausal Women with Advanced Breast Cancer

Brief summary

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.

Detailed description

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.

Interventions

OTHERGnRh Analogue and Aromatase Inhibitor

GnRh Analogue and Aromatase Inhibitor

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

45 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Receptor Positive Premenopausal Women with Advanced Breast Cancer.

Exclusion criteria

* Any woman other than diagnosis of Receptor Positive Premenopausal with Advanced Breast Cancer.

Countries

Saudi Arabia

Contacts

Primary ContactAl Sayed, M.D.

+966-1-4423949

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026